{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T05:33:08Z","timestamp":1773552788870,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":2314,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ad.2012.03.007","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T12:04:08Z","timestamp":1342785848000},"page":"738-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["La formulaci\u00f3n magistral en la terap\u00e9utica dermatol\u00f3gica actual"],"prefix":"10.1016","volume":"104","author":[{"given":"M.","family":"S\u00e1nchez-Rega\u00f1a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Llamb\u00ed-Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Salleras-Redonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Iglesias Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Collgros Totosaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Umbert-Millet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2012.03.007_bib0005","first-page":"52","article-title":"La formulaci\u00f3n magistral: una opci\u00f3n de futuro en Espa\u00f1a","volume":"360","year":"2010","journal-title":"Farmac\u00e9uticos"},{"key":"10.1016\/j.ad.2012.03.007_bib0010","unstructured":"USP Pharmacopeia. 35 ed. Monograf\u00eda 795 Rockville, USA; 2011."},{"key":"10.1016\/j.ad.2012.03.007_bib0015","unstructured":"Consejo de Europa. Resoluci\u00f3n CM\/ResAP (2011) 1. Exigencias relativas a la garant\u00eda de calidad y de inocuidad de los medicamentos preparados en las farmacias para las necesidades especiales de los pacientes. Estrasburgo, enero. Rockville:United States Pharmacopeia Convention Inc.: 2011. [consultado 23 feb 2012]. Disponible en: http:\/\/www.cofares.es\/FileDownload.aspx?Key=FILES&Log=True&id=23601"},{"key":"10.1016\/j.ad.2012.03.007_bib0020","article-title":"Ley 29\/2006 sobre garant\u00edas y Uso racional del medicamento y productos sanitarios","volume":"178","year":"2006","journal-title":"BOE"},{"key":"10.1016\/j.ad.2012.03.007_bib0025","article-title":"Real Decreto 175\/2001 sobre Normas de correcta elaboraci\u00f3n y control de calidad en formulaciones magistrales y preparados oficinales","volume":"65","year":"2001","journal-title":"BOE"},{"key":"10.1016\/j.ad.2012.03.007_bib0030","series-title":"La formulaci\u00f3n en la dermatolog\u00eda del 2010","first-page":"15","article-title":"Aporte de la formulaci\u00f3n a la terap\u00e9utica actual","author":"Umbert","year":"2008"},{"key":"10.1016\/j.ad.2012.03.007_bib0035","first-page":"35","article-title":"Desabastecimientos, formulaci\u00f3n y criterios sanitarios","volume":"11","author":"Llamb\u00ed","year":"2011","journal-title":"El Farmac\u00e9utico"},{"key":"10.1016\/j.ad.2012.03.007_bib0040","series-title":"La formulaci\u00f3n en la dermatolog\u00eda del 2010","first-page":"39","article-title":"Nuevos veh\u00edculos en formulaci\u00f3n dermatolog\u00eda","author":"Llamb\u00ed","year":"2008"},{"key":"10.1016\/j.ad.2012.03.007_bib0045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0213-9251(09)72026-X","article-title":"Nuevos veh\u00edculos para formulaci\u00f3n dermatol\u00f3gica","volume":"24","author":"Llamb\u00ed","year":"2009","journal-title":"Piel"},{"key":"10.1016\/j.ad.2012.03.007_bib0050","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0001-7310(09)70534-4","article-title":"Tratamiento t\u00f3pico de la psoriasis","volume":"100","author":"Carrascosa","year":"2009","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2012.03.007_bib0055","series-title":"Mild-to-Moderate Psoriasis","first-page":"3","article-title":"General approach to psoriasis treatment","author":"Feldman","year":"2006"},{"key":"10.1016\/j.ad.2012.03.007_bib0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.piel.2010.04.006","article-title":"La formulaci\u00f3n magistral en Dermatolog\u00eda, hoy en d\u00eda","volume":"25","author":"Aizp\u00fan","year":"2010","journal-title":"Piel"},{"key":"10.1016\/j.ad.2012.03.007_bib0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2230.2005.01773.x","article-title":"Electrical measurement of moisturizing effect on skin hydration and barrier function in psoriasis patients","volume":"30","author":"Rim","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0190-9622(92)70076-R","article-title":"Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid","volume":"26","author":"Lavker","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000051729","article-title":"Vitamin B12 cream containing avocado oil in the therapy of plaque psoriasis","volume":"203","author":"St\u00fcccker","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2012.03.007_bib0080","first-page":"15","article-title":"Topical vitamin B12: evaluation of its efficacy in plaque-type psoriasis","volume":"3","author":"S\u00e1nchez-Rega\u00f1a","year":"2011","journal-title":"Revista Latinoamericana de Psoriasis y Artritis psori\u00e1sica"},{"key":"10.1016\/j.ad.2012.03.007_bib0085","first-page":"334","article-title":"Topical tacrolimus for the treatment of psoriasis of psoriasis of the face, genitalia, intertriginous areas and corporal plaques","volume":"5","author":"Mart\u00edn-Ezquerra","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0090","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2133.2008.08442.x","article-title":"Topical treatment of mild to moderate plaque psoriasis with 0,3% tacrolimus gel and 0,5% tacrolimus cream: the effects on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression","volume":"158","author":"Vissers","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/09546630701846087","article-title":"Topical preparation for the treatment of psoriasis: results of a retrospective study over 15 years","volume":"19","author":"Zampetti","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2012.03.007_bib0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000278241","article-title":"Dithranol therapy in childhood psoriasis: unjustifiably on the verge of falling into oblivion","volume":"220","author":"de Jarger","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2012.03.007_bib0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2340\/00015555-1096","article-title":"Positive effect of modified Goeckerman regimen on quality of life and psychosocial distress in moderate and severe psoriasis","volume":"91","author":"Chern","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2012.03.007_bib0110","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1365-2133.2007.08201.x","article-title":"Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g (-1) ointment and tacrolimus 0,3 ug g (-1) oinment in chronic plaque psoriasis involging facial or genitofemoral areas: a double-blind randomized controlled trial","volume":"157","author":"Liao","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0115","series-title":"Proceedings of the xxxviii Congreso Nacional de la Academia Espa\u00f1ola de Dermatolog\u00eda y Venereolog\u00eda","article-title":"Psoriasis ungueal: tratamiento con ung\u00fcento de tazaroteno al 0,1%","author":"Fischer","year":"2010"},{"key":"10.1016\/j.ad.2012.03.007_bib0120","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-4632.2006.02911.x","article-title":"The treatment of psoriasis vulgaris: 1% topical methotrexate gel","volume":"45","author":"Eskicirak","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0213-9251(02)72549-5","article-title":"Empleo de calcipotriol t\u00f3pico en la psoriasis ungueal","volume":"17","author":"S\u00e1nchez-Rega\u00f1a","year":"2002","journal-title":"Piel"},{"key":"10.1016\/j.ad.2012.03.007_bib0130","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/09546630902787585","article-title":"Tacalcitol ointment for the treatment of nail psoriasis","volume":"20","author":"M\u00e1rquez","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2012.03.007_bib0135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1468-3083.2005.01253.x","article-title":"Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients","volume":"19","author":"S\u00e1nchez-Rega\u00f1a","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.03.007_bib0140","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1468-3083.2008.02679.x","article-title":"Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol oinment","volume":"22","author":"S\u00e1nchez-Rega\u00f1a","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.03.007_bib0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0001-7310(08)74613-1","article-title":"Aspectos diagn\u00f3sticos y terap\u00e9uticos de la psoriasis ungueal","volume":"99","author":"S\u00e1nchez Rega\u00f1a","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2012.03.007_bib0150","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2230.2007.02568.x","article-title":"Prevalence of fungal involvement in a series of patients with nail psoriasis","volume":"33","author":"S\u00e1nchez Rega\u00f1a","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0155","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0001-7310(09)71901-5","article-title":"Psoriasis del cuero cabelludo","volume":"100","author":"Sola","year":"2009","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2012.03.007_bib0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ad.2010.11.002","article-title":"Documento de consenso de fototerapia en psoriasis del grupo espa\u00f1ol de psoriasis: UVBBE, l\u00e1ser, fuentes monocrom\u00e1ticas de exc\u00edmeros y terapia fotodin\u00e1mica","volume":"102","author":"Carrascosa","year":"2011","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2012.03.007_bib0165","first-page":"290","article-title":"Optimization of narrow-band UVB with 5% oleic acid cream in the treatment of psoriasis","volume":"6","author":"Martin","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0170","series-title":"La formulaci\u00f3n en la dermatolog\u00eda del 2010","first-page":"157","article-title":"Psoriasis","author":"S\u00e1nchez-Rega\u00f1a","year":"2008"},{"issue":"Suppl. 6","key":"10.1016\/j.ad.2012.03.007_bib0175","first-page":"24S","article-title":"Long term safety and efficacy study of adapalene 0.3% gel","volume":"7","author":"Weiss","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0180","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaad.2006.10.005","article-title":"Two Randomized studies demonstrate the efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris","volume":"56","author":"Draelos","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0185","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/09546630903440064","article-title":"Combination of azelaic acid 5% and erytromicin 2% in the treatment of acne vulgaris","volume":"21","author":"Pazoki-Toroudi","year":"2010","journal-title":"J Dematol Treat"},{"key":"10.1016\/j.ad.2012.03.007_bib0190","first-page":"405","article-title":"Clindamycin 1.2% and retinoid acid 0.025%: vehicle, stability and tolerability","volume":"81","author":"Del Rosso","year":"2008","journal-title":"Cutis"},{"key":"10.1016\/j.ad.2012.03.007_bib0195","first-page":"736","article-title":"Efficacy and tolerability of a fixed combination of clindamycin phosphate (1,2%) and low concentration benzoyl peroxide (2,5%) aqueous gel in moderate or severe acne subpopulations","volume":"8","author":"Webster","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D30N81Z2H4","article-title":"Tazarotene 0,1% cream plus clindamycin 1% versus tretinoin 0.025% plus clindamycin 1% gel in the treatment of facial acne vulgaris","volume":"13","author":"Tanghetti","year":"2007","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ad.2012.03.007_bib0205","first-page":"118","article-title":"Developing a retinoid oral liquid for patients who cannot take capsules","volume":"14","author":"McElhiney","year":"2010","journal-title":"Int J Pharmaceutical Compounding"},{"key":"10.1016\/j.ad.2012.03.007_bib0210","first-page":"607","article-title":"Efficacy of topical azelaic acid gel 15% plus oral doxixycline 40mg versus metronidazol gel 1% plus oral doxicycline 40mg in mild-to moderate papulopustular rosacea","volume":"9","author":"Del Rosso","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0215","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-4632.2005.02769.x","article-title":"Azelaic acid in the treatment of acne rosacea","volume":"46","author":"Gupta","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0220","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"The randomized phase clinical trials evaluating antiinflammatory dose doxyciclyne administered once daily for treatment of rosacea","volume":"56","author":"Del Rosso","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.ad.2012.03.007_bib0225","article-title":"Melanocytes dendricity down-regulated by the association of niacinamide-ascorbic acid","volume":"60","author":"Ionescu","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0230","series-title":"La formulaci\u00f3n en la dermatolog\u00eda del 2010","first-page":"223","article-title":"Patolog\u00edas de la mucosa oral","author":"Iglesias","year":"2008"},{"key":"10.1016\/j.ad.2012.03.007_bib0235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/sj.bdj.4806042","article-title":"Clorhexidine gluconate mouthwash in the management in minor aphtous ulceration: a double-blind placebo-controlled cross-over trial","volume":"162","author":"Hunter","year":"1987","journal-title":"Br Dent J"},{"key":"10.1016\/j.ad.2012.03.007_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D31658K5FQ","article-title":"Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis: a randomized cross-over study","volume":"13","author":"Gorsky","year":"2007","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ad.2012.03.007_bib0245","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2796.1994.tb00805.x","article-title":"Sucralfate suspension as a treatment of recurrent aphthous stomatitis","volume":"236","author":"Rattan","year":"1994","journal-title":"J Intern Med"},{"key":"10.1016\/j.ad.2012.03.007_bib0250","first-page":"7","article-title":"The efficacy of topical 0,2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behcet\u0301s disease","volume":"17","author":"Lee","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.03.007_bib0255","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-0714.2006.00433.x","article-title":"The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration","volume":"35","author":"Nolan","year":"2006","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ad.2012.03.007_bib0260","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2230.1992.tb00195.x","article-title":"Topical tretinoin: a new treatment for black hairy tongue (lingua villosa nigra)","volume":"17","author":"Langtry","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0265","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1600-0714.2008.00688.x","article-title":"Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations","volume":"38","author":"Carbone","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ad.2012.03.007_bib0270","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/archderm.134.12.1521","article-title":"Treatment of lichen planus. An evidence-Based Medicine Analysis of Efficacy","volume":"134","author":"Cribier","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0275","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2009.03.012","article-title":"Calcineurin inhibitors in oral medicine","volume":"61","author":"Al Johani","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0280","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2133.2007.08370.x","article-title":"The efficacy of aloe vera gel in the treatment of oral lichen planus: a randomised controlled trial","volume":"158","author":"Choonhakarn","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0285","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1600-0714.2010.00947.x","article-title":"Efficacy of topical Aloe vera in patients with oral lichen planus: a randomized double-blind study","volume":"39","author":"Salazar-S\u00e1nchez","year":"2010","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ad.2012.03.007_bib0290","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/MAJ.0b013e3182171164","article-title":"Comparison of aloe vera mouthwash with triamcinolone acetonide 0,1% on oral lichen planus: a randomised double-blinded clinical trial","volume":"342","author":"Mansourian","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ad.2012.03.007_bib0295","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1346-8138.2006.00128.x","article-title":"Oral zinc sulfate in the treatment of Beh\u00e7et's disease: a double blind cross-over study","volume":"33","author":"Sharquie","year":"2006","journal-title":"J Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0300","first-page":"734","article-title":"The therapeutic and prophilactic role of oral zinc sulfate in management of recurrent aphthous stomatitis in comparison with dapsone","volume":"29","author":"Khalifa","year":"2008","journal-title":"Saudi Med J"},{"key":"10.1016\/j.ad.2012.03.007_bib0305","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00128071-200405020-00004","article-title":"Levamisole in dermatology: a review","volume":"5","author":"Scheinfeld","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archdermatol.2008.591","article-title":"Successful treatment of complex aphthosis with colchicine and dapsone","volume":"145","author":"Lynde","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0315","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0714.2007.00507.x","article-title":"Subantimicrobial dose doxycycline in the treatment of recurrent oral aphthous ulceration: a pilot study","volume":"36","author":"Preshaw","year":"2007","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ad.2012.03.007_bib0320","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaad.2008.07.001","article-title":"Medical treatments for male and female pattern hair loss","volume":"59","author":"Rogers","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0325","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0001-7310(08)74673-8","article-title":"Manejo de la alopecia androgen\u00e9tica en mujeres posmenop\u00e1usicas","volume":"99","author":"Rivera","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2012.03.007_bib0330","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.sder.2009.01.001","article-title":"Hair loss in women","volume":"28","author":"Camacho-Mart\u00ednez","year":"2009","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.ad.2012.03.007_bib0335","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00128071-200708050-00003","article-title":"Efficacy of 5% minoxidil versus combined 5% minoxidil and 0,01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial","volume":"8","author":"Shin","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0340","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000076497","article-title":"Topical estrogen therapy for androgenetic alopecia in menopausal females","volume":"208","author":"Georgala","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2012.03.007_bib0345","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaad.2011.05.026","article-title":"A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0,1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia","volume":"66","author":"Blume-Peytavi","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0350","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000079890","article-title":"Swiss Trichology Study Group. Finasteride treatment of patterned hair los in normoandrogenic postmenopausal women","volume":"209","author":"Trueb","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2012.03.007_bib0355","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archderm.142.3.298","article-title":"Finasterida treatment of female pattern hair loss","volume":"142","author":"Iorizzo","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0360","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.sder.2008.12.002","article-title":"Alopecia areata: Evidence-based treatments","volume":"28","author":"Garg","year":"2009","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.ad.2012.03.007_bib0365","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0213-9251(09)70758-0","article-title":"Tratamiento de la alopecia areata (i). Tratamientos locales","volume":"24","author":"Mart\u00ednez","year":"2009","journal-title":"Piel"},{"key":"10.1016\/j.ad.2012.03.007_bib0370","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archderm.1987.01660350091020","article-title":"Evaluation of anthralin in the treatment of alopecia areata","volume":"123","author":"Fiedler-Weiss","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0375","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2009.10.031","article-title":"Alopecia areata update Part II. Treatment","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0380","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1067\/mjd.2003.423","article-title":"Clobetasol propionate 0,05% under occlusion in the treatment of alopecia totalis\/universalis","volume":"49","author":"Tosti","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0385","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3949\/ccjm.56.2.149","article-title":"Extensive alopecia areata. Results of treatment with 3% topical minoxidil","volume":"56","author":"Ranchoff","year":"1989","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.ad.2012.03.007_bib0390","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0190-9622(87)80003-8","article-title":"Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata","volume":"16","author":"Fiedler-Weis","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0395","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0974-7753.77511","article-title":"Bimatoprost in the treatment of eyelashes alopecia in alopecia areata universalis","volume":"2","author":"Ojeda","year":"2010","journal-title":"Int J Trichol"},{"key":"10.1016\/j.ad.2012.03.007_bib0400","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1468-3083.2009.03543.x","article-title":"Latanoprost in the treatment of eyelashes alopecia in alopecia areata universalis","volume":"24","author":"Coronel-P\u00e9rez","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.03.007_bib0405","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1468-3083.2007.02411.x","article-title":"Alopecia areata: topical immunotherapy treatment with diphencyprone","volume":"22","author":"Avgerinou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.03.007_bib0410","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1468-3083.2005.01226.x","article-title":"Alopecia areata treatment with a phototoxic dose of UVA and topical 8 methoxipsoralen","volume":"19","author":"Mohamed","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.03.007_bib0415","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2133.1995.tb06925.x","article-title":"PUVA treatment of alopecia areata partialis, totalis and universalis: Audit of 10 years experience at St Joh\u0144s Institute of Dermatology","volume":"133","author":"Taylor","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0420","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1067\/mjd.2001.110060","article-title":"The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alpecia areata","volume":"44","author":"Behrens-Williams","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.03.007_bib0425","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5021\/ad.2009.21.2.142","article-title":"The therapeutic effect and the changed serum zinc level after zinc supplementation in alopecia areata patients who had a low serum zinc level","volume":"21","author":"Park","year":"2009","journal-title":"Ann Dermatol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731012002128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731012002128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:00:28Z","timestamp":1757552428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731012002128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":85,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0001731012002128"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2012.03.007","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La formulaci\u00f3n magistral en la terap\u00e9utica dermatol\u00f3gica actual","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2012.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Espa\u00f1a, S.L. and AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}